Desk›Healthcare› HealthCare Global Enterprises Ltd
HealthCare Global Enterprises Ltd
BSE 539787 · NSE HCG · ISIN INE075I01017 · Group A · Active
Healthcare › Healthcare › Healthcare Services › Hospital
₹695.65
-0.65%
BSE close, 28 August 2026
₹10,386.21 cr
14.9 cr shares · Small cap
₹3,676.20 cr
as published
621.1× · 8.50×
EPS ₹1.12 · BV ₹81.84
1,365.30 / 14.58
₹ cr, as filed
27
8 selected · 30%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -13.0% |
|---|---|
| Against 52-week low | +35.5% |
| Day change | -0.65% |
| Size band | Small cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹1.12 |
|---|---|
| Price / earnings | 621.12× |
| Price / book | 8.50× |
| Book value — derived, price ÷ P/B | ₹81.84 |
| Return on equity | 1.37% |
| Operating margin | 18.26% |
| Net margin | 1.48% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- 1.37%
- ROE as published
- 1.37%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 376.66 | 5.58 | 0.37 | 18.26% | 1.48% |
| Mar-26 · Q | 350.21 | 1.53 | 0.11 | 12.15% | 0.44% |
| FY25-26 | 1,365.30 | 14.58 | 1.03 | 15.81% | 1.07% |
Quarter on quarter
- Revenue, quarter on quarter
- +7.6%
- Net profit, quarter on quarter
- +264.7%
- Operating margin, quarter on quarter
- +611 bps
Disclosure profile 27 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Acquisition | 2 |
| Board Outcome | 1 |
| Change in Management | 1 |
| Concall Transcript | 1 |
| Investor Presentation | 1 |
| Press Release | 1 |
| Results | 1 |
| Selected sub-total | 8 |
| Procedural | |
| Analyst / Investor Meet | 5 |
| AGM / EGM | 3 |
| General | 2 |
| Newspaper Publication | 2 |
| Annual Report | 1 |
| BRSR | 1 |
| Board Meeting | 1 |
| Monitoring Agency | 1 |
| Other Update | 1 |
| Subsidiary Incorporation | 1 |
| Trading Window | 1 |
| Procedural sub-total | 19 |
| Total | 27 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group A, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
27 filings · 8 selected · busiest 2026-08-06
Filing rhythm · the twelve most recent
2026-08-272026-10-05
SelectedProcedural
Filings
27 in the window · 7 earlier on record
-
5 October 2026 ·
Acquisition
Pursuant to Regulation 30 of SEBI Listing Regulations, we would like to inform you that Healthcare Global (Kenya) Private Limited, a step-down subsidiary of the Company has today, i.e., ....
Company Update / Acquisition View filing →
-
30 September 2026 ·
Closure of Trading Window
Intimation regarding closure of Trading Window of the Company for the quarter and half year ending September 30, 2026.
Insider Trading / SAST / Closure of Trading Window View filing →
-
18 September 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Scrutinizer's Report and Voting Results for the agenda(s) listed in the Notice of 28th Annual General Meeting of the Company.
AGM/EGM / AGM View filing →
-
18 September 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
Intimation regarding summary of proceedings of 28th Annual General Meeting of the Company.
AGM/EGM / AGM View filing →
-
17 September 2026 ·
Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure requirements), Regulations 2015
Company Update / Analyst / Investor Meet View filing →
-
16 September 2026 ·
Analyst / Investor Meet - Intimation
Intimation of Schedule of meetings with Institutional Investors at Mumbai.
Company Update / Analyst / Investor Meet View filing →
-
9 September 2026 ·
Intimation Of Grant Of Employee Stock Options Under Healthcare Global Enterprises Limited- Employee Stock Option Scheme, 2026
The Nomination and Remuneration Committee of the Board of Directors of the Company, at its meeting held today, i.e., September 09, 2026, has approved grant of Employee Stock Options to ....
Company Update / General View filing →
-
28 August 2026 ·
Letter To Members Of The Company Containing Weblink And Path Of Integrated Annual Report For The Financial Year 2025-26.
Please note that letters are being dispatched to the Members of the Company containing web link and path of Integrated Annual Report for Financial Year 2025-26.
Company Update / General View filing →
-
28 August 2026 ·
Newspaper Publication
Newspaper advertisement pertaining to dispatch of 28th Annual General Meeting and Integrated Annual Report for FY 2025-26.
Company Update / Newspaper Publication View filing →
-
27 August 2026 ·
Notice Of 28Th Annual General Meeting Of The Company For FY 2025-26.
Please find enclosed the Notice of 28th Annual General Meeting and Integrated Annual Report of the Company for FY 2025-26.
AGM/EGM / AGM View filing →
-
27 August 2026 ·
Reg. 34 (1) Annual Report.
Please find enclosed the Integrated Annual Report of the Company for FY 2025-26.
Others / Reg. 34 (1) Annual Report View filing →
-
27 August 2026 ·
Business Responsibility and Sustainability Reporting (BRSR)
Please find enclosed the Business Responsibility and Sustainability Report ("BRSR") of the Company for FY 2026.
Others / Business Responsibility and Sustainability Reporting (BRSR) View filing →
-
25 August 2026 ·
Newspaper Publication
Newspaper advertisement pertaining to Notice of Annual General Meeting in accordance with MCA General Circular No. 20/2020 dated May 05, 2020.
Company Update / Newspaper Publication View filing →
-
10 August 2026 ·
Earnings Call Transcript
Please find attached herewith the Transcript of Earnings Call held on August 07, 2026, with Analysts/Investors to discuss the Unaudited Financial Results (Standalone and Consolidated) of ....
Company Update / Earnings Call Transcript View filing →
-
7 August 2026 ·
Analyst / Investor Meet - Intimation
This is to inform that the Company will be participating in the group investor meeting hosted by Ambit Capital in Bangalore.
Company Update / Analyst / Investor Meet View filing →
-
7 August 2026 ·
Analyst / Investor Meet - Outcome
This is to inform you that the Audio recording of the Earnings Call with Analysts/Investors held on August 07, 2026, to discuss the Unaudited Financial Results (Standalone and Consolidated) ....
Company Update / Analyst / Investor Meet View filing →
-
6 August 2026 ·
Press Release / Media Release
Press release on Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2026.
Company Update / Press Release / Media Release View filing →
-
6 August 2026 ·
Investor Presentation
Investor Presentation on Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2026.
Company Update / Investor Presentation View filing →
-
6 August 2026 ·
Monitoring Agency Report
Monitoring Agency Report for the quarter ended June 30, 2026, in relation to the Rights Issue of the Company..
Company Update / Monitoring Agency Report View filing →
-
6 August 2026 ·
Statement Of Variation Or Deviation Of The Proceeds Of Rights Issue For The Quarter Ended June 30, 2026.
Statement of Variation or Deviation for funds raised through Rights Issue for the quarter ended June 30, 2026.
Company Update / Reg. 32 (1), (3) - Statement of Deviation & Variation View filing →
-
6 August 2026 ·
Change in Management
The Board of Directors has approved the re-appointment of M/s Rao Murthy & Associates, Cost Accountants as Cost Auditors of the Company for the financial year 2026-27.
Company Update / Change in Management View filing →
-
6 August 2026 ·
Acquisition
The Board of Directors of the Company has approved a further investment of up to INR 16 Crores in HCG Rajkot Hospitals LLP, a wholly-owned subsidiary of the Company.
Company Update / Acquisition View filing →
-
6 August 2026 ·
Unaudited Financial Results Of The Company For The Quarter Ended June 30, 2026.
Unaudited Financial Results of the Company for the quarter ended June 30, 2026.
Result / Financial Results View filing →
-
6 August 2026 ·
Board Meeting Outcome for Outcome Of Board Meeting- August 06, 2026
The Company has announced the Outcome of the Board meeting held on August 06, 2026, including approval of unaudited financial results of the Company for the quarter ended June 30, 2026.
Board Meeting / Outcome of Board Meeting View filing →
-
4 August 2026 ·
Acquisition
Pursuant to Regulation 30 of LODR, we would like to inform that HCG Manavata Oncology LLP, a subsidiary LLP, of the Company has entered into agreement to acquire 26% equity stake in Epic ....
Company Update / Acquisition View filing →
-
27 July 2026 ·
Analyst / Investor Meet - Intimation
Further to the intimation submitted to Stock Exchanges dated July 27, 2026, with respect to the meeting of the Board of Directors of the Company, to be held on Thursday, August 06, 2026, ....
Company Update / Analyst / Investor Meet View filing →
-
27 July 2026 ·
Board Meeting Intimation for Considering And Approving Inter-Alia, The Unaudited Financial Results (Both Standalone And Consolidated) Of The Company For The Quarter Ended June 30, 2026 ('Financial Results').
Healthcare Global Enterprises Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2026 ,inter alia, to consider and approve the Unaudited ....
Board Meeting / Board Meeting View filing →
RSS feed for HealthCare Global Enterprises Ltd · the 50 most recent filings